FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151750209> ?p ?o ?g. }

• W2151750209 endingPage "872" @default.
• W2151750209 startingPage "870" @default.
• W2151750209 abstract "HomeCirculationVol. 114, No. 9The Heat Is on Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBThe Heat Is onHeat-Shock Proteins and Atherosclerosis Georg Wick, MD Georg WickGeorg Wick From the Division of Experimental Pathophysiology and Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. Search for more papers by this author Originally published29 Aug 2006https://doi.org/10.1161/CIRCULATIONAHA.106.647875Circulation. 2006;114:870–872It is common knowledge that atherosclerosis is a multifactorial disease, and the disease-promoting role of classic risk factors for atherosclerosis, such as high serum cholesterol levels, diabetes, hypertension, smoking, and various types of infections, has been proven in innumerable clinical studies. Despite the fact that we are dealing with a chronic disease, however, there is a surprising scarcity of reports dealing with the very first stages of atherogenesis, ie, those that are not yet leading to clinical symptoms. It is now evident that inflammatory/immunologic processes play a major role in the development of atherosclerosis. The correlation between the presence and amount of inflammatory surrogate markers and the occurrence of sonographically demonstrable early arterial changes becomes more significant the earlier in the course of the disease that these analyses are performed. Although complicated atherosclerotic lesions, as the name implies, are composed of many different cellular and extracellular constituents, the earliest lesions are characterized by intimal infiltration by mononuclear cells often still without the presence of foam cells, especially in those instances in which risk factors other than high serum cholesterol levels are operative. In this context, it is important to remember that the first intima-infiltrating cells in early, clinically nonapparent lesions are lymphoid cells, followed by blood-borne monocytes, and finally smooth muscle cells immigrating from the media.1 Later, both the scavenger receptor–expressing macrophages and smooth muscle cells may transform into foam cells accompanied by fibroblast and myofibroblast proliferation with collagenous and noncollagenous extracellular matrix protein deposition leading to the paradigmatic hardening of the arterial wall. The antigenic specificity of early intima-infiltrating lymphoid cells is still to be determined.Article p 886In this issue of Circulation, Park et al2 address the possible role of heat shock protein (HSP) 27 in atherogenesis. HSPs have risen to prominence in atherosclerosis research for 2 reasons: (1) They represent the response of cells of the vessel wall to various stressors, notably classic atherosclerosis risk factors, and (2) they are targets for innate and adaptive immune reactions initiating and perpetuating the vascular inflammatory process. HSPs are classified into various families according to their molecular weight, ranging from large (90 to 100 kDa) to very small (<10 kDa) forms. HSPs are among the phylogenetically most conserved molecules showing a high-sequence homology from prokaryotes to humans. Thus, there is a >97% homology of HSP60 between different bacterial species, and bacterial and human HSP60 still display a >55% overall homology, amounting to >70% at certain molecular domains. Under physiological conditions, HSPs fulfill important roles for intracellular protein folding, transport, and degradation. Under stress conditions, they also act as chaperones, ie, they associate with other cellular proteins and protect them from denaturation.3HSP60 and HSP70 have received increasing attention in atherosclerosis research, whereas little has been published on HSP27 on this context. Thus, immobilization or surgical stress leads to an upregulation of inducible HSP70 and HSP27 in rats on both RNA and protein levels. The greatest abundance of HSP70 expression was observed in the adrenal system, followed by the vascular system, notably in the aorta.4On being subjected to atherosclerosis risk factors, both HSP60 and HSP70 are expressed by endothelial cells at those territories of the arterial vessels that are subjected to turbulent rather than laminar shear stress flow conditions, ie, at the vascular branching points. Venous endothelial cells usually do not express HSP60 or HSP70. However, when they come under arterial blood pressure and flow conditions, eg, when used as arterial-venous bypass conduits, endothelial HSP60 expression and intimal mononuclear cell infiltration, which follows, are the first events that later lead to restenosis.5HSP60 has attracted interest not only as a stress response and chaperone molecule but also as an important microbial and autoantigen, the latter representing biochemically modified autologous HSP60 released after cellular necrosis. Because during her or his lifetime every normal human being has mounted an immune response against microbial HSP60 and has developed bona fide autoimmunity against biochemically altered autologous HSP60, this protective defense may have to be “paid for” by a cross-reactivity with HSP60 expressed on stressed endothelial cells at the mentioned predilection sites for the development of atherosclerotic lesions. HSP70 does not seem to play a triggering role for the immunologic autoreactive process because in experimental animals only immunization with HSP60 but not HSP70 leads to the development of the first inflammatory stage of atherosclerosis.6HSP27 forms dimers and tetramers that after phosphorylation associate with cytoskeletal actin and act as filament stabilizers under stress conditions.7 Furthermore, HSP27 is able to interfere with the apoptotic pathway, eg, by interacting with Daxx and Fas.8 It can also inhibit the release of the proapoptotic molecule Smac/Diablo9 and block the intrinsic pathway by increasing the retention of cytochrome c.10HSP27 has also been described to play an important role in promoting tumor genesis and growth,11 affording cellular protection in the central nervous system12 and exerting a chaperone function in the epidermis.13 In regard to the cardiovascular system, HSP27 expression has been found to be altered in congestive heart failure14 and is upregulated in stressed or vascular endothelial cell growth factor–activated human endothelial cells.15 It has also been reported that proinflammatory mediators (C-reactive protein) and cytokines (interleukin-6, tumor necrosis factor-α) are able to upregulate HSP27 expression.16The possible role of HSP27 in atherogenesis has been addressed only recently.17 In this issue of Circulation, Park et al2 studied the expression of HSP27 in human atherosclerotic plaques as well as the increased plasma levels of HSP27 in patients with acute coronary syndrome. Using 2-dimensional gel electrophoresis and Western blotting, the investigators analyzed 3 types of arterial tissues for the expression of HSP27, ie, atherosclerotic plaques, nearby normal-appearing areas from the same vessels, and nonatherosclerotic reference arteries. Of the list of many differentially expressed proteins, only HSP27 was studied in depth.Interestingly, the authors found significantly increased HSP27 expression in the adjacent normal-appearing vessel areas compared with unaffected reference vessels. However, the phosphorylation of HSP27 was most pronounced in the normal reference arteries, intermediate in the adjacent normal-appearing areas, and lowest in the plaque core. In addition, in the lesional core region a lower degree of HSP27 expression emerged compared with areas adjacent to plaques. These findings were corroborated by immunohistological staining of the respective regions.Analysis of the HSP27-containing area of 2-dimensional gels showed a surprisingly high number of spots, probably indicating posttranslational modification of the molecule. It would be interesting to investigate whether autoantibodies against these modified forms or fragments of HSP27 are formed during atherogenesis. That these various spots were indeed HSP27 was corroborated by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry. In contrast to the increased expression of HSP27 in the normal-appearing adjacent areas, the phosphorylation of HSP27 was decreased at this site, entailing a significantly lower phospho-HSP27/total HSP27 expression ratio in the adjacent area compared with normal arterial tissue. In the plaque core areas, phospho-HSP70 was barely detectible. The expression of HSP70 was higher in both the plaque core areas and the adjacent normal-appearing areas compared with the normal reference tissue. The expression of β-actin was not different in any of the 3 types of specimens.The fact that the highest degree of HSP27 expression was observed in the still normal-appearing area adjacent to the atherosclerotic plaque seems plausible because this is where the action is, ie, where inflammatory processes are most prominent. HSP27 has to be phosphorylated before fulfilling its chaperone function,17 and again the gradation in the degree of phosphorylation from normal reference arteries over the adjacent normal-appearing area toward the plaque supports this course of events.The decrease of HSP27 expression toward the atherosclerotic core may be explained by the inversely increased proteolytic activity17: Atherosclerotic plaques contain ample amounts of proteases, and extracellular HSP27 will therefore be degraded, whereas intracellularly located HSP27 in the adjacent still normal-appearing area is protected from this proteolytic process.Can HSP27 be used as a diagnostic serum parameter similar to soluble HSP60?18,19 The authors show that there is no difference in HSP27 serum levels between a normal healthy reference group and a group having risk factors for coronary artery disease. In contrast to the known situation with HSP60 and HSP70, circulating levels of HSP27 do not seem to be correlated with risk factors for coronary artery disease, but significantly higher levels are seen in patients with acute coronary syndrome. Again, it would be interesting to also determine anti-HSP27 antibodies and perhaps HSP27-reactive peripheral blood T cells as additional parameters.In summary, this article supports the notion that the stress response of the various cellular components of the vessel wall is an important trigger of atherogenesis, especially the earliest inflammatory stages that may still be accessible to modern diagnostic, preventive, and therapeutic measures. In addition to its chaperoning function during this process, it may be of interest to also address the possible role of HSP27 as an antigen recognized by the innate and/or adaptive immune system.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.DisclosuresNone.FootnotesCorrespondence to Georg Wick, MD, Division of Experimental Pathophysiology and Immunology, Biocenter, Medical University of Innsbruck, Fritz-Pregl-Strasse 3/IV, A-6020 Innsbruck, Austria. E-mail [email protected] References 1 Xu QB, Oberhuber G, Gruschwitz M, Wick G. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol. 1990; 56: 344–359.CrossrefMedlineGoogle Scholar2 Park HK, Park E-C, Bae SW, Park MY, Kim SW, Yoo HS, Tudev M, Ko YH, Choi YH, Kim S, Kim D-I, Kim YW, Lee BB, Yoon JB, Park JE. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation. 2006; 114: 886–893.LinkGoogle Scholar3 Craig EA, Gambill BD, Nelson RJ. Heat shock proteins: molecular chaperones of protein biogenesis. Microbiol Rev. 1993; 57: 402–414.CrossrefMedlineGoogle Scholar4 Udelsman R, Blake MJ, Stagg CA, Li DG, Putney DJ, Holbrook NJ. Vascular heat shock protein expression in response to stress: endocrine and autonomic regulation of this age-dependent response. J Clin Invest. 1993; 91: 465–473.CrossrefMedlineGoogle Scholar5 Knoflach M, Mayrl B, Mayerl C, Sedivy R, Wick G. Atherosclerosis as a paradigmatic disease of the elderly: role of the immune system. Immunol Allergy Clin North Am. 2003; 23: 117–132.CrossrefMedlineGoogle Scholar6 Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol. 2004; 22: 361–403.CrossrefMedlineGoogle Scholar7 Mounier N, Arrigo AP. Actin cytoskeleton and small heat shock proteins: how do they interact? Cell Stress Chaperones. 2002; 7: 167–176.CrossrefMedlineGoogle Scholar8 Charette SJ, Lavoie JN, Lambert H, Landry J. Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol. 2000; 20: 7602–7612.CrossrefMedlineGoogle Scholar9 Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N, Catley L, Tai YT, Hayashi T, Shringarpure R, Burger R, Munshi N, Ohtake Y, Saxena S, Anderson KC. Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance. Blood. 2003; 102: 3379–3386.CrossrefMedlineGoogle Scholar10 Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S, Arrigo AP. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol. 2002; 22: 816–834.CrossrefMedlineGoogle Scholar11 Laudanski K, Wyczechowska D. The distinctive role of small heat shock proteins in oncogenesis. Arch Immunol Ther Exp (Warsz). 2006; 54: 103–111.CrossrefMedlineGoogle Scholar12 Franklin TB, Krueger-Naug AM, Clarke DB, Arrigo AP, Currie RW. The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system. Int J Hyperthermia. 2005; 21: 379–392.CrossrefMedlineGoogle Scholar13 Jonak C, Metze D, Traupe H, Happle R, Konig A, Trautinger F. The expression of the 27-kd heat shock protein in keratinization disorders: an immunohistological study. Hum Pathol. 2005; 36: 686–693.CrossrefMedlineGoogle Scholar14 Dohke T, Wada A, Isono T, Fujii M, Yamamoto T, Tsutamoto T, Horie M. Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Card Fail. 2006; 12: 77–84.CrossrefMedlineGoogle Scholar15 Pawlowska Z, Baranska P, Jerczynska H, Koziolkiewicz W, Cierniewski CS. Heat shock proteins and other components of cellular machinery for protein synthesis are up-regulated in vascular endothelial cell growth factor-activated human endothelial cells. Proteomics. 2005; 5: 1217–1227.CrossrefMedlineGoogle Scholar16 Njemini R, Lambert M, Demanet C, Mets T. The effect of aging and inflammation on heat shock protein 27 in human monocytes and lymphocytes. Exp Gerontol. 2006; 41: 312–319.CrossrefMedlineGoogle Scholar17 Martin-Ventura JL, Nicolas V, Houard X, Blanco-Colio LM, Leclercq A, Egido J, Vranckx R, Michel JB, Meilhac O. Biological significance of decreased HSP27 in human atherosclerosis. Arterioscler Thromb Vasc Biol. 2006; 26: 1337–1343.LinkGoogle Scholar18 Xu Q, Schett G, Perschinka H, Mayr M, Egger G, Oberhollenzer F, Willeit J, Kiechl S, Wick G. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation. 2000; 102: 14–20.LinkGoogle Scholar19 Pockley AG, Wu R, Lemne C, Kiessling R, de Faire U, Frostegard J. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension. 2000; 36: 303–307.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Sato S, Sugiura M and Kurihara T (2018) Dimer-monomer equilibrium of human HSP27 is influenced by the in-cell macromolecular crowding environment and is controlled by fatty acids and heat, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 10.1016/j.bbapap.2018.04.003, 1866:5-6, (692-701), Online publication date: 1-May-2018. Tian M, Zhu L, Lin H, Lin Q, Huang P, Yu X and Jing Y (2017) Hsp-27 levels and thrombus burden relate to clinical outcomes in patients with ST-segment elevation myocardial infarction, Oncotarget, 10.18632/oncotarget.17852, 8:43, (73733-73744), Online publication date: 26-Sep-2017. Stolzenburg N, Breinl J, Bienek S, Jaguszewski M, Löchel M, Taupitz M, Speck U, Wagner S and Schnorr J (2016) Paclitaxel-Coated Balloons: Investigation of Drug Transfer in Healthy and Atherosclerotic Arteries – First Experimental Results in Rabbits at Low Inflation Pressure, Cardiovascular Drugs and Therapy, 10.1007/s10557-016-6658-1, 30:3, (263-270), Online publication date: 1-Jun-2016. Nakayoshi T, Adachi H, Ohbu-Murayama K, Enomono M, Fukami A, Kumagai E, Nakamura S, Nohara Y, Nakao E, Sasaki K and Fukumoto Y (2016) Plasma heat shock protein 27 is increased in renal dysfunction and habitual smoking in a Japanese general population, Journal of Cardiology, 10.1016/j.jjcc.2015.04.005, 67:1, (110-114), Online publication date: 1-Jan-2016. Boshoff A (2015) Chaperonin—Co-chaperonin Interactions The Networking of Chaperones by Co-chaperones, 10.1007/978-3-319-11731-7_8, (153-178), . Uyy E, Ivan L, Boteanu R, Suica V and Antohe F (2013) High-fat diet alters protein composition of detergent-resistant membrane microdomains, Cell and Tissue Research, 10.1007/s00441-013-1697-4, 354:3, (771-781), Online publication date: 1-Dec-2013. Ghayour-Mobarhan M, Saber H and Ferns G (2012) The potential role of heat shock protein 27 in cardiovascular disease, Clinica Chimica Acta, 10.1016/j.cca.2011.04.005, 413:1-2, (15-24), Online publication date: 1-Jan-2012. Vidyasagar A, Wilson N and Djamali A (2012) Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target, Fibrogenesis & Tissue Repair, 10.1186/1755-1536-5-7, 5:1, Online publication date: 1-Dec-2012. Newby A (2012) Macrophages and Atherosclerosis Inflammation and Atherosclerosis, 10.1007/978-3-7091-0338-8_17, (331-352), . Mehta T (2010) Heat Shock Proteins in Vascular Disease Heat Shock Proteins and Whole Body Physiology, 10.1007/978-90-481-3381-9_6, (103-119), . Ivan L and Antohe F (2010) Hyperlipidemia induces endothelial-derived foam cells in culture, Journal of Receptors and Signal Transduction, 10.3109/10799891003630606, 30:2, (106-114), Online publication date: 1-Apr-2010. Besgen P, Trommler P, Vollmer S and Prinz J (2010) Ezrin, Maspin, Peroxiredoxin 2, and Heat Shock Protein 27: Potential Targets of a Streptococcal-Induced Autoimmune Response in Psoriasis, The Journal of Immunology, 10.4049/jimmunol.0903520, 184:9, (5392-5402), Online publication date: 1-May-2010. Paier A, Agewall S and Kublickiene K (2009) Expression of heat shock proteins and nitrotyrosine in small arteries from patients with coronary heart disease, Heart and Vessels, 10.1007/s00380-008-1117-y, 24:4, (260-266), Online publication date: 1-Jul-2009. Businaro R, Profumo E, Tagliani A, Buttari B, Leone S, D’Amati G, Ippoliti F, Leopizzi M, D’Arcangelo D, Capoano R, Fumagalli L, Salvati B and Riganò R (2009) Heat-shock protein 90: A novel autoantigen in human carotid atherosclerosis, Atherosclerosis, 10.1016/j.atherosclerosis.2009.04.026, 207:1, (74-83), Online publication date: 1-Nov-2009. Bottoni P, Giardina B and Scatena R (2009) Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications, PROTEOMICS - Clinical Applications, 10.1002/prca.200800195, 3:6, (636-653), Online publication date: 1-Jun-2009. Delaleu N, Madureira A, Immervoll H and Jonsson R (2008) Inhibition of experimental Sjögren's syndrome through immunization with HSP60 and its peptide amino acids 437-460, Arthritis & Rheumatism, 10.1002/art.23656, 58:8, (2318-2328), Online publication date: 1-Aug-2008. Matt P, Fu Z, Carrel T, Huso D, Dirnhofer S, Lefkovits I, Zerkowski H and Van Eyk J (2007) Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve, Journal of Molecular and Cellular Cardiology, 10.1016/j.yjmcc.2007.08.011, 43:6, (792-801), Online publication date: 1-Dec-2007. August 29, 2006Vol 114, Issue 9 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCULATIONAHA.106.647875PMID: 16940202 Originally publishedAugust 29, 2006 KeywordsatherosclerosisEditorialsinflammationheat-shock proteinsPDF download Advertisement SubjectsPathophysiology" @default.
• W2151750209 created "2016-06-24" @default.
• W2151750209 creator A5034145989 @default.
• W2151750209 date "2006-08-29" @default.
• W2151750209 modified "2023-10-16" @default.
• W2151750209 title "The Heat Is on" @default.
• W2151750209 cites W1936320257 @default.
• W2151750209 cites W1966976216 @default.
• W2151750209 cites W1969963389 @default.
• W2151750209 cites W1992038850 @default.
• W2151750209 cites W1994905572 @default.
• W2151750209 cites W2021665051 @default.
• W2151750209 cites W2032040187 @default.
• W2151750209 cites W2032773922 @default.
• W2151750209 cites W2065006023 @default.
• W2151750209 cites W2070671821 @default.
• W2151750209 cites W2074257329 @default.
• W2151750209 cites W2123921117 @default.
• W2151750209 cites W2136347732 @default.
• W2151750209 cites W2148209200 @default.
• W2151750209 cites W2156110752 @default.
• W2151750209 cites W2162754641 @default.
• W2151750209 cites W2169210465 @default.
• W2151750209 cites W2269326075 @default.
• W2151750209 doi "https://doi.org/10.1161/circulationaha.106.647875" @default.
• W2151750209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16940202" @default.
• W2151750209 hasPublicationYear "2006" @default.
• W2151750209 type Work @default.
• W2151750209 sameAs 2151750209 @default.
• W2151750209 citedByCount "24" @default.
• W2151750209 countsByYear W21517502092012 @default.
• W2151750209 countsByYear W21517502092013 @default.
• W2151750209 countsByYear W21517502092014 @default.
• W2151750209 countsByYear W21517502092016 @default.
• W2151750209 countsByYear W21517502092017 @default.
• W2151750209 countsByYear W21517502092018 @default.
• W2151750209 countsByYear W21517502092022 @default.
• W2151750209 crossrefType "journal-article" @default.
• W2151750209 hasAuthorship W2151750209A5034145989 @default.
• W2151750209 hasBestOaLocation W21517502091 @default.
• W2151750209 hasConcept C177713679 @default.
• W2151750209 hasConcept C71924100 @default.
• W2151750209 hasConceptScore W2151750209C177713679 @default.
• W2151750209 hasConceptScore W2151750209C71924100 @default.
• W2151750209 hasIssue "9" @default.
• W2151750209 hasLocation W21517502091 @default.
• W2151750209 hasLocation W21517502092 @default.
• W2151750209 hasOpenAccess W2151750209 @default.
• W2151750209 hasPrimaryLocation W21517502091 @default.
• W2151750209 hasRelatedWork W1506200166 @default.
• W2151750209 hasRelatedWork W1995515455 @default.
• W2151750209 hasRelatedWork W2039318446 @default.
• W2151750209 hasRelatedWork W2048182022 @default.
• W2151750209 hasRelatedWork W2080531066 @default.
• W2151750209 hasRelatedWork W2748952813 @default.
• W2151750209 hasRelatedWork W2899084033 @default.
• W2151750209 hasRelatedWork W3032375762 @default.
• W2151750209 hasRelatedWork W3108674512 @default.
• W2151750209 hasRelatedWork W4252371801 @default.
• W2151750209 hasVolume "114" @default.
• W2151750209 isParatext "false" @default.
• W2151750209 isRetracted "false" @default.
• W2151750209 magId "2151750209" @default.
• W2151750209 workType "article" @default.